BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1176 related articles for article (PubMed ID: 33761203)

  • 1. New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
    Abdool Karim SS; de Oliveira T
    N Engl J Med; 2021 May; 384(19):1866-1868. PubMed ID: 33761203
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronavirus variants are spreading in India - what scientists know so far.
    Vaidyanathan G
    Nature; 2021 May; 593(7859):321-322. PubMed ID: 33976409
    [No Abstract]   [Full Text] [Related]  

  • 3. Audio Interview: The Omicron Variant of SARS-CoV-2.
    Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S
    N Engl J Med; 2021 Dec; 385(23):e96. PubMed ID: 34874638
    [No Abstract]   [Full Text] [Related]  

  • 4. Fast-spreading COVID variant can elude immune responses.
    Callaway E
    Nature; 2021 Jan; 589(7843):500-501. PubMed ID: 33479534
    [No Abstract]   [Full Text] [Related]  

  • 5. The long road.
    Cohen J
    Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
    [No Abstract]   [Full Text] [Related]  

  • 6. Pfizer COVID vaccine protects against worrying coronavirus variants.
    Callaway E
    Nature; 2021 May; 593(7859):325-326. PubMed ID: 33963317
    [No Abstract]   [Full Text] [Related]  

  • 7. Heavily mutated Omicron variant puts scientists on alert.
    Callaway E
    Nature; 2021 Dec; 600(7887):21. PubMed ID: 34824381
    [No Abstract]   [Full Text] [Related]  

  • 8. Audio Interview: Vaccination and Variants in the U.S. and South Africa.
    Rubin EJ; Baden LR; Gray GE; Morrissey S
    N Engl J Med; 2021 May; 384(19):e85. PubMed ID: 33979495
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
    Cevik M; Grubaugh ND; Iwasaki A; Openshaw P
    Cell; 2021 Sep; 184(20):5077-5081. PubMed ID: 34534444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omicron's feeble attack on the lungs could make it less dangerous.
    Kozlov M
    Nature; 2022 Jan; 601(7892):177. PubMed ID: 34987210
    [No Abstract]   [Full Text] [Related]  

  • 11. Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Sep; 385(12):e48. PubMed ID: 34525292
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 vaccine breakthrough infections.
    Gupta RK; Topol EJ
    Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How severe are Omicron infections?
    Ledford H
    Nature; 2021 Dec; 600(7890):577-578. PubMed ID: 34934198
    [No Abstract]   [Full Text] [Related]  

  • 14. Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
    Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S
    N Engl J Med; 2021 Jan; 384(2):e14. PubMed ID: 33497556
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac.
    Chen Y; Shen H; Huang R; Tong X; Wu C
    Lancet Infect Dis; 2021 Aug; 21(8):1071-1072. PubMed ID: 34051887
    [No Abstract]   [Full Text] [Related]  

  • 16. How bad is Omicron? What scientists know so far.
    Callaway E; Ledford H
    Nature; 2021 Dec; 600(7888):197-199. PubMed ID: 34857948
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel SARS-CoV-2 variants: the pandemics within the pandemic.
    Boehm E; Kronig I; Neher RA; Eckerle I; Vetter P; Kaiser L;
    Clin Microbiol Infect; 2021 Aug; 27(8):1109-1117. PubMed ID: 34015535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multitude of coronavirus variants found in the US - but the threat is unclear.
    Callaway E
    Nature; 2021 Mar; 591(7849):190. PubMed ID: 33674807
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
    Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients.
    Trombetta CM; Marchi S; Viviani S; Manenti A; Benincasa L; Ruello A; Bombardieri E; Vicenti I; Zazzi M; Montomoli E
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.